Quanterix Corp (QTRX) - Medical Equipment - Deals and Alliances Profile
October 2018
57
About the Report
About the Report
Summary
Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix's kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company's Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.
Quanterix Corp (QTRX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Quanterix Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Quanterix Corp, Medical Equipment, Deal Details 12
Venture Financing 12
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12
Aushon BioSystems Raises USD3.6 Million in Financing Round 13
Quanterix Raises USD46 Million in Series D Financing 14
Aushon BioSystems Raises USD8 million in Venture Financing 16
Quanterix Raises USD 1 Million In Venture Financing 17
Quanterix Raises USD 19 Million In Series C Financing 18
Aushon BioSystems Raises USD 5.5 Million In Venture Financing 20
Quanterix Raises USD 2 Million In Venture Financing 21
Quanterix Secures Investment In Venture Financing 22
Partnerships 23
Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24
Quanterix Enters into Agreement with DestiNA Genomics 25
ADx NeuroSciences Enters into Agreement with Quanterix 26
Quanterix Enters into Agreement with Frontage Labs 27
Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30
Equity Offering 31
Quanterix Raises USD73.7 Million in IPO 31
Quanterix Raises USD8.5 Million in Private Placement 33
Quanterix Invests in Immunarray 34
Acquisition 35
Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35
Quanterix Corp-Key Competitors 36
Quanterix Corp-Key Employees 37
Quanterix Corp-Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Strategy And Business Planning 39
Jun 15, 2017: Frontage Laboratories Announces Partnership With Quanterix And Validation Of Simoa Hd-1 Analyzer And Software To Support Biomarker Analysis 39
Financial Announcements 40
Aug 08, 2018: Quanterix releases operating results for second quarter 2018 40
May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 41
Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 42
Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 43
Corporate Communications 44
Aug 03, 2017: Quanterix Raises USD 8.5 Million In Private Financing Led By T. Rowe Price Associates; Also Appoints Dr. Marijn Dekkers To Company'S Board Of Directors And Several Key Executives To Its Leadership Team 44
Product News 45
Oct 09, 2018: Quanterix Simoa Technology powers record number of presentations and poster sessions at ECTRIMS 2018 45
Jul 23, 2018: Quanterix' Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans 46
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 47
Aug 15, 2017: Quanterix To Launch High-Sensitivity Benchtop Instrument And Assays For Multiplex Biomarker Detection 48
Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 49
Jul 06, 2017: Single Molecule Microrna Technology Proves Useful for Liver Toxicity Detection 50
May 17, 2017: Quanterix Launches The First Comprehensive Multiplex Panel To Study Traumatic Brain Injury Severity 51
Apr 14, 2017: Quanterix To Present Webinar On Protein Quantification And Identification In Personalized Medicine 52
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 53
Other Significant Developments 54
Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 54
Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 55
May 09, 2017: Smithers Avanza Adds Quanterix' Simoa Technology To Bioanalytical Laboratory 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
List of Figure
List of Figures
Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
Quanterix Corp, Medical Equipment, Key Facts, 2017 2
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Deals By Market, 2012 to YTD 2018 9
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12
Aushon BioSystems Raises USD3.6 Million in Financing Round 13
Quanterix Raises USD46 Million in Series D Financing 14
Aushon BioSystems Raises USD8 million in Venture Financing 16
Quanterix Raises USD 1 Million In Venture Financing 17
Quanterix Raises USD 19 Million In Series C Financing 18
Aushon BioSystems Raises USD 5.5 Million In Venture Financing 20
Quanterix Raises USD 2 Million In Venture Financing 21
Quanterix Secures Investment In Venture Financing 22
Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24
Quanterix Enters into Agreement with DestiNA Genomics 25
ADx NeuroSciences Enters into Agreement with Quanterix 26
Quanterix Enters into Agreement with Frontage Labs 27
Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30
Quanterix Raises USD73.7 Million in IPO 31
Quanterix Raises USD8.5 Million in Private Placement 33
Quanterix Invests in Immunarray 34
Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35
Quanterix Corp, Key Competitors 36
Quanterix Corp, Key Employees 37
Quanterix Corp, Subsidiaries 38
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.